Corticosteroid treatment of Alzheimer's disease: is S100A9/Mrp14 a key target?

被引：4
|
作者：
Kametani, Fuyuki [1 ]
机构：
[1] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan
来源：
NEUROBIOLOGY OF AGING | 2014年 / 35卷 / 04期
关键词：
CEREBRAL AMYLOID ANGIOPATHY;
D O I：
10.1016/j.neurobiolaging.2013.10.083
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：E11 / E12
页数：2
相关论文
共 50 条
  • [41] Emerging targets for cancer treatment: S100A9/RAGE
    Valiente, M.
    Sepulveda, J. M.
    Perez, A.
    [J]. ESMO OPEN, 2023, 8 (01)
  • [42] ULTRASTRUCTURAL-LOCALIZATION OF THE S-100-LIKE PROTEINS MRP8 AND MRP14 IN MONOCYTES IS CALCIUM-DEPENDENT
    BURWINKEL, F
    ROTH, J
    GOEBELER, M
    BITTER, U
    WROCKLAGE, V
    VOLLMER, E
    ROESSNER, A
    SORG, C
    BOCKER, W
    [J]. HISTOCHEMISTRY, 1994, 101 (02) : 113 - 120
  • [43] A KEY ROLE OF S100A9 IN THE PATHOGENESIS OF PSORIATIC ARTHRITIS IN TTP/S100 DEFICIENT MICE
    Froehling, M.
    Vogl, T.
    Loser, K.
    Paruzel, P.
    Blackshear, P. J.
    Stumpo, D. J.
    Roth, J.
    Pap, T.
    Stratis, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A13 - A13
  • [44] Tetrameric S100A8/S100A9 alarmin is a key regulator of cellular dynamics in monocytes
    Vogl, Thomas
    Russo, Antonella
    Fischer-Riepe, Lena
    Betz, Timo
    Roth, Johannes
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 207 - 207
  • [45] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
  • [46] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651
  • [47] Myeloid-Related Protein-14/MRP-14/S100A9/Calgranulin B is Associated with Inflammation in Proliferative Diabetic Retinopathy
    Abu El-Asrar, Ahmed M.
    Alam, Kaiser
    Siddiquei, Mohammad M.
    Van den Eynde, Kathleen
    Mohammad, Ghulam
    De Hertogh, Gert
    Opdenakker, Ghislain
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (04) : 615 - 624
  • [48] Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro
    Manitz, MP
    Horst, B
    Seeliger, S
    Strey, A
    Skryabin, BV
    Gunzer, M
    Frings, W
    Schönlau, F
    Roth, J
    Sorg, C
    Nacken, W
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (03) : 1034 - 1043
  • [49] S100A8 and S100A9 in inflammation and cancer
    Gebhardt, Christoffer
    Nemeth, Julia
    Angel, Peter
    Hess, Jochen
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1622 - 1631
  • [50] S100A8 and S100A9 in inflammatory diseases
    Roth, J
    Goebeler, M
    Sorg, C
    [J]. LANCET, 2001, 357 (9261): : 1041 - 1041
12345